ReviewBioengineering & translational medicine2026
Cell-embedded microgels as emerging miniature 3D tissue-mimics toward biochip-based toxicity screening.
Review in Bioengineering & translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent developments in synthetic three-dimensional (3D) gel microenvironments for cell culture have enabled the advancement of bioengineered organ-specific cell niches that resemble the native 3D tissue architecture and mechanics. In particular, the application of 3D cell cultures based on miniaturized hydrogel scaffolds for toxicological analyses is attracting increasing interest because of their facile adaptability to on-chip systems and potential as novel in vitro screening tools. We summarize the current progress in microgel-based 3D cells integrated into biochip platforms and their utilization for the in vitro toxicity evaluation of chemicals and drug candidates. We emphasize the development of tissue-mimicking microgel systems combined with automated gel microarray chips and organ-on-a-chip devices. This review begins with the microscale hydrogel scaffolds that encapsulate mammalian cells and are used for in vitro tissue mimicry purposes. Furthermore, an overview of microgel-based tissue modeling approaches to toxicity testing and screening is provided, along with their technical advantages in drug discovery and alternatives to animal testing.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.